| Literature DB >> 35746236 |
Chih-Ta Yen1, Un-Hung Chen2, Guo-Chang Wang2, Zong-Xian Chen2.
Abstract
This study proposed a noninvasive blood glucose estimation system based on dual-wavelength photoplethysmography (PPG) and bioelectrical impedance measuring technology that can avoid the discomfort created by conventional invasive blood glucose measurement methods while accurately estimating blood glucose. The measured PPG signals are converted into mean, variance, skewness, kurtosis, standard deviation, and information entropy. The data obtained by bioelectrical impedance measuring consist of the real part, imaginary part, phase, and amplitude size of 11 types of frequencies, which are converted into features through principal component analyses. After combining the input of seven physiological features, the blood glucose value is finally obtained as the input of the back-propagation neural network (BPNN). To confirm the robustness of the system operation, this study collected data from 40 volunteers and established a database. From the experimental results, the system has a mean squared error of 40.736, a root mean squared error of 6.3824, a mean absolute error of 5.0896, a mean absolute relative difference of 4.4321%, and a coefficient of determination (R Squared, R2) of 0.997, all of which fall within the clinically accurate region A in the Clarke error grid analyses.Entities:
Keywords: back-propagation neural network (BPNN); bioelectrical impedance; blood glucose estimation; photoplethysmography (PPG); principal component analysis (PCA)
Mesh:
Substances:
Year: 2022 PMID: 35746236 PMCID: PMC9229484 DOI: 10.3390/s22124452
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.847
Figure 1Dual-wavelength photoplethysmography (PPG) measurement waveform (blue line denotes red light, red line denotes infrared light); (a) original unprocessed PPG waveform; (b) PPG waveform filtered by a Savitzky–Golay filter.
Physiological characteristics of the participants.
| Parameters | Daily Activity |
|---|---|
| Age Range (years) | 18–25 |
| Height (cm) | 165 ± 20 |
| Weight (kg) | 65 ± 30 |
| Heart rate (bpm) | 70 ± 28 |
| Blood flow rate (mm/s) | 280 ± 100 |
| Hemoglobin (g/L) | 160 ± 20 |
| Pulse oximetry (%) | 94 ± 5 |
| blood glucose (mg/dL) | 110 ± 15 |
Figure 2Experimental environment and equipment layout: (a) the PPG waveform measuring instrument; (b) the bioelectrical impedance value measuring instrument; (c) a commercially available noninvasive glucose meter.
Figure 3Flow chart of the clinical trial.
Figure 4Experimental system architecture.
Figure 5Proposed BPNN architecture.
Input characteristic values used by the BPNN.
| 1 | Infrared light | 2 | Red light PPG mean | 3 | Infrared light variance |
| 4 | Infrared light | 5 | Infrared light PPG skewness | 6 | Red light PPG skewness |
| 7 | Infrared light | 8 | Red light PPG kurtosis | 9 | Infrared light PPG standard deviation |
| 10 | Red light PPG standard deviation | 11 | Infrared light PPG Information Entropy | 12 | Red light PPG Information Entropy |
| 13 | Age (years) | 14 | Height (cm) | 15 | Weight (kg) |
| 16 | Heart rate (bpm) | 17 | Blood flow rate (mm/s) | 18 | Hemoglobin (g/L) |
| 19 | Pulse oximetry (%) | 20 | Frequency 50k Bioelectrical Impedance values | 21 | Frequency 55k Bioelectrical Impedance values |
| 22 | Frequency 60k Bioelectrical Impedance values | 23 | Frequency 65k Bioelectrical Impedance values | 24 | Frequency 70k Bioelectrical Impedance values |
| 25 | Frequency 75k Bioelectrical Impedance values | 26 | Frequency 80k Bioelectrical Impedance values | 27 | Frequency 85k Bioelectrical Impedance values |
| 28 | Frequency 90k Bioelectrical Impedance values | 29 | Frequency 95k Bioelectrical Impedance values | 30 | Frequency 100k Bioelectrical Impedance values |
Figure 6Training convergence curve.
Figure 7Clarke error grid.
Comparison of noninvasive blood glucose assessment systems.
| Reference | Modality | MSE | RMSE | MAE | MARD |
| Clarke EGA |
|---|---|---|---|---|---|---|---|
| Hina et al. [ | NIRS | N/A | 11.20 | N/A | 7.62% | 0.937 | 95% in the A area |
| Hina et al. [ | NIRS | N/A | 10.20 | N/A | 6.9% | 0.955 | N/A |
| Gupta et al. [ | NIRS | N/A | N/A | N/A | N/A | 0.88 | N/A |
| Guzman et al. [ | NIRS | N/A | 18.6621 | 16.4540 | N/A | N/A | N/A |
| Zhu et al. [ | NIRS | N/A | N/A | N/A | 5.453% | 0.936 | 98.413% in the A area |
| Zeng et al. [ | BIS | N/A | N/A | N/A | N/A | 0.99 | N/A |
| Nanayakkara et al. [ | BIS + NIRS | N/A | 10.24 | N/A | N/A | 0.58 | 90% in the A area |
| Pathirage et al. [ | BIS + NIRS | N/A | N/A | N/A | 9.3% | N/A | 86.1% in the A area |
| Fouad et al. [ | BIS + NIRS | N/A | N/A | N/A | N/A | 0.918 | 100% in the A area |
| This work | BIS + NIRS | 40.736 | 6.3824 | 5.0896 | 4.4321% | 0.9970 | 100% in the A area |